Literature DB >> 200219

The gross architecture of an antibody-combining site as determined by spin-label mapping.

B J Sutton, P Gettins, D Givol, D Marsh, S Wain-Hobson, K J Willan, R A Dwek.   

Abstract

1. A series of Dnp (dinitrophenyl) nitroxide spin labels was used to map the dimensions of the combining site of the Dnp-binding immunoglobulin A myeloma protein MOPC 315. The method compares the observed e.s.r. (electron-spin-resonance) hyperfine splittings with those calculated on the basis of different postulated motions for the spin label. The analysis is complicated by the sensitivity of the e.s.r. hyperfine splitting to the overall ;tumbling' time of the antibody-hapten complex and the polarity of the spin-label's environment. When these effects are considered quantitatively, it is then possible to determine the degree of mobility of each hapten which is allowed by the shape of the combining site. 2. The dinitrophenyl ring is rigidly held, and the depth of the site is 1.1-1.2nm and has lateral dimensions at the entrance to the site >/=0.6nmx0.9nm. The analysis of the results for spin-labelled haptens with chiral centres allows these lateral dimensions to be refined to 0.8nm and 1.1nm, and it is shown that the site is asymmetric with respect to the plane of the dinitrophenyl ring. 3. A polarity profile of the combining site was also obtained and a positively charged amino acid residue, possibly arginine-95(L) (light chain), was located at the entrance to the site. 4. The binding of Gd(III) to the antibody-hapten complexes results in quenching of the e.s.r. signal of the nitroxide. By using La(III) as a control, the paramagnetic contribution to the quenching is measured. 5. Analysis of the differential quenchings of the enantiomers of two five-membered nitroxide ring spin labels gives two possible locations of the metal-binding site. One of these is equidistant (0.7nm) from each of the three dinitrophenyl aromatic protons, and nuclear-magnetic-resonance relaxation studies, at 270MHz, on solutions of dinitrobenzene, Gd(III) and the Fv fragment (variable region of heavy and light chain) from protein MOPC 315 support this location for the metal site. 6. The e.s.r. and metal-binding data were then compared with the results of a model of the combining site constructed on the basis of framework invariance in immunoglobulins [Padlan, Davies, Pecht, Givol & Wright (1976) Cold Spring Harbor Symp. Quant. Biol.41, in the press]. The overall agreement is very good. Assignments of possible chelating groups for the metal can be made.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200219      PMCID: PMC1164889          DOI: 10.1042/bj1650177

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

Review 1.  Structural studies in solution on the combining site of the myeloma protein MOPC 315.

Authors:  R A Dwek
Journal:  Contemp Top Mol Immunol       Date:  1977

2.  Comparison of the dimensions of the combining sites of the dinitrophenyl-binding immunoglobulin A myeloma proteins MOPC 315, MOPC 460 and XRPC 25 by spin-label mapping.

Authors:  K J Willan; D Marsh; C A Sunderland; B J Sutton; S Wain-Hobson; R A Dwek; D Givol
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

3.  Difficulties in determining accurate molecular motion parameters from proton relaxation enhancement measurements as illustrated by the immunoglobulin G-Gd(III) system.

Authors:  D R Burton; S Forsén; G Karlström; R A Dwek; A C McLaughlin; S Wain-Hobson
Journal:  Eur J Biochem       Date:  1976-12-11

4.  Antibody--hapten interactions in solution.

Authors:  R A Dwek; R Jones; D Marsh; A C McLaughlin; E M Press; N C Price; A I White
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1975-11-06       Impact factor: 6.237

5.  Structural properties of the ligand binding sites of murine myeloma proteins.

Authors:  J C Hsia; J R Little
Journal:  FEBS Lett       Date:  1973-04-01       Impact factor: 4.124

6.  Rotational correlation time of spin-labeled alpha-chymotrypsin.

Authors:  E J Shimshick; H M McConnell
Journal:  Biochem Biophys Res Commun       Date:  1972-01-14       Impact factor: 3.575

7.  Spin-labeling as a general method in studying antibody active site.

Authors:  J C Hsia; L H Piette
Journal:  Arch Biochem Biophys       Date:  1969-01       Impact factor: 4.013

8.  A spin-labeled hapten.

Authors:  L Stryer; O H Griffith
Journal:  Proc Natl Acad Sci U S A       Date:  1965-12       Impact factor: 11.205

9.  Absence of lysine from the DNP-lysine binding site of protein 315; designation of lysine 52 of the heavy chain as a peripheral residue.

Authors:  J Klostergaard; A L Grossberg; L M Krausz; D Pressman
Journal:  Immunochemistry       Date:  1977-01

10.  Magnetic resonance studies of spin-labeled creatine kinase system and interaction of two paramagnetic probes.

Authors:  J S Taylor; J S Leigh; M Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

View more
  4 in total

1.  Comparison of the dimensions of the combining sites of the dinitrophenyl-binding immunoglobulin A myeloma proteins MOPC 315, MOPC 460 and XRPC 25 by spin-label mapping.

Authors:  K J Willan; D Marsh; C A Sunderland; B J Sutton; S Wain-Hobson; R A Dwek; D Givol
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

2.  Crystallization of the Fv fragment of mouse myeloma protein M315.

Authors:  R Aschaffenburg; D C Phillips; D R Rose; B J Sutton; S K Dower; R A Dwek
Journal:  Biochem J       Date:  1979-08-01       Impact factor: 3.857

3.  Specificity of interactions of hapten side chains with the combining site of the myeloma protein MOPC 315.

Authors:  S Wain-Hobson; S K Dower; P Gettins; D Givol; A C McLaughlin; I Pecht; C A Sunderland; R A Dwek
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

4.  Homogeneous antibody fragment conjugation by disulfide bridging introduces 'spinostics'.

Authors:  Felix F Schumacher; Vishal A Sanchania; Berend Tolner; Zoë V F Wright; Chris P Ryan; Mark E B Smith; John M Ward; Stephen Caddick; Christopher W M Kay; Gabriel Aeppli; Kerry A Chester; James R Baker
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.